EMEA-000568-PIP01-09-M06
Key facts
| Invented name |
Cinryze
|
| Active substance |
C1 inhibitor (human)
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0299/2015
|
| PIP number |
EMEA-000568-PIP01-09-M06
|
| Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
| Condition(s) / indication(s) |
Treatment of C1 inhibitor deficiency
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
NPS Pharma Holdings Limited
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000568-PIP01-09-M06
|
| Compliance opinion date |
26/02/2016
|
| Compliance outcome |
positive
|